Autoimmune hypoglycemia expands the biological spectrum of HHV8(+) multicentric Castleman disease

Autoimmune hypoglycemia belongs to the clinical spectrum of HHV8(+) MCD and rituximab is an effective treatment of this condition. This rare complication is related to autoantibodies directed toward the insulin receptor and activating the insulin signaling pathway.

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Arnautou, Pierre, Auclair, Martine, Fellahi, Soraya, Bouché, Clara, Fieschi, Claire, Barrak, Elias, Queyrel-Moranne, Viviane, Chaillous, Lucy, Blin, Nicolas, Malphettes, Marion, Fadlallah, Jehane, Bertinchamp, Remi, Gérard, Laurence, Bengoufa, Djaouida, Galicier, Lionel, Oksenhendler, Eric, Vigouroux, Corinne, Boutboul, David
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2021
Fag:
Stimulus Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045508/
https://ncbi.nlm.nih.gov/pubmed/33787862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002801
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker